References
- Olson WH, Miles WM, Zipes DP, et al. Intracardiac electrical impedance during ventricular tachycardia and ventricular fibrillation in man. J Am Coll Cardiol 1985; 5(2):506
- Venditti FJ, Qiang ZZ, Grubelich F, et al. Hemodynamic stability of tachyarrhythmia as determined by use of pulmonary artery O2 saturation monitoring. Pacing Clin Electrophysiol 1991; 14(Part II):708
- Hiles MC, Bourland JD, Wessale JL, et al. Detection of ventricular tachycardia and fibrillation using coronary sinus blood temperature: a feasibility study. Pacing Clin Electrophysiol 1993; 16(12): 2266–78
References
- Mehra R, Cybulski Z. Tachyarrhythmia termination: lead systems and hardware design. In: Singer I, ed. Implantable cardioverter-defibrillator. Armonk, NY: Futura, 1994:71
References
- Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335(26):1933–40
- Hallstrom AP, AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators (AVID): rationale, design, and methods. Am J Cardiol 1995; 75(7):470–5
- Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980; 303(6):322–4
- Naccarelli GV, Dougherty AH. Unit 7, Implantable cardioverter-defibrillators. In: Naccarelli GV, ed. EPSAP (Electro-physiology self-assessment program). Bethesda: American College of Cardiology, 1996
- Mirowski M, Reid PR, Winkle RA, et al. Mortality in patients with implanted automatic defibrillators. Ann Intern Med 1983; 98(5 Pt l):585–8
- Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321(6):406–12
- Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992; 327(4):227–33
- Anderson KP, DeCamilla J, Moss AJ. Clinical significance of ventricular tachycardia (3 beats or longer) detected during ambulatory monitoring after myocardial infarction. Circulation 1978; 57(5): 890–7
- Bigger JT Jr, Fleiss JL, Kleiger R, et al. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984; 69(2): 250–8
- Buxton AE, Marchlinski FE, Waxman HL, et al. Prognostic factors in nonsustained ventricular tachycardia. Am J Cardiol 1984; 53(9): 1275–9
- NASPE Policy Conference Committee. Implantable cardioverter defibrillators in cardiovascular practice: report of the Policy Conference of the North American Society of Pacing and Electrophysiology. Pacing Clin Electrophysiol 1991; 14(6):969–79
- Winkle RA, Mead RH, Ruder MA, et al. Improved low energy defibrillation efficacy in man with the use of a biphasic truncated exponential waveform. Am Heart J 1989; 117(l):122–7
- Bardy GH, Johnson G, Poole JE, et al. A simplified, single-lead unipolar transvenous cardioversion-defibrillation system. Circulation 1993; 88(2):543–7
- Olson WH. Tachycardia sensing and detection. In: Singer I, ed. Implantable cardioverter-defibrillator. Armonk, NY: Futura, 1994:71
- Mehra R, Cybulski Z. Tachyarrhythmia termination: lead systems and hardware design. In: Singer I, ed, 14 p 109